. Primers used in this study primer sequence (5' -3') VapB30-f GGAATTCCATATGGCGCTGAGTATCAAGCACC VapB30-r CCGCTCGAGTCAGGCCGGCAATCC VapC30-f VapC30 of crystal forms I (left) and II (right). Residues Gly89−Arg92 in the putative RNA binding loop are disordered in crystal form I, while the entire region is visible in crystal form II. Residues Gly87−Asn96 of crystal form II (chain A) are represented as stick models with its electron density map (mFo-Fc; contoured at 1σ, colored yellow) (B) Structural overlay of the four copies of VapB30 of crystal forms I (left) and II (right). The slightly different orientations and secondary structure elements in the Cterminal region of VapB30 suggest that this region is dynamic. Crystal form I Crystal form II A B α5 α6 α5 α6 Linker between α5 and α6
is the intensity of reflection h,  h is the sum over all reflections, and  i is the sum over i measurements of reflection h. c R =  | |F obs | -|F calc | | /  |F obs |, where R free was calculated from a randomly chosen 5% of reflections, that were not used for structure refinement and R work was calculated from the remaining reflections. d Values obtained using REFMAC (39). e Values obtained using MolProbity (41). Figure S9 . Fluorescence time course experiments measuring disruption of VapBC30 complex (10 μM) by designed peptides at increasing concentrations (10−100 μM) . The negative control contained 1 mM MgCl 2 , 0.5 M NaCl, 20 mM Tris-HCl buffer pH 8.0, 40 units of RiboLock TM (Thermo scientific) RNase inhibitor, and 100 μM of peptide I,II, and III. 100 μM of 11-mer randomized peptide (Asp-Ser-Leu-Glu-Phe-Ile-Ala-Ser-Lys-Leu-Ala) was incubated with 10 μM VapBC30 and used as control. Data shown is representative of three replicate experiments.
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